Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 11,511 | 11,689 | 9,761 | 11,956 | 4,335 |
| Cost of Goods | 3,774 | 1,955 | 2,037 | 2,019 | 2,333 |
| Gross Profit | 7,737 | 9,734 | 7,724 | 9,937 | 2,002 |
| Operating Expenses | 54,419 | 41,520 | 42,052 | 44,371 | 43,043 |
| Operating Income | -45,908 | -30,831 | -34,291 | -34,415 | -40,708 |
| Interest Expense | 67 | 231 | 6,382 | 12,723 | 8,421 |
| Other Income | -8,022 | -8,189 | -1,228 | -1,257 | -3,471 |
| Pre-tax Income | -53,997 | -39,251 | -41,901 | -48,395 | -52,600 |
| Net Income Continuous | -53,997 | -39,251 | -41,901 | -48,395 | -52,600 |
| Minority Interests | -563 | -759 | -601 | -941 | -5 |
| Net Income | $-53,434 | $-38,492 | $-41,300 | $-47,454 | $-52,595 |
| EPS Basic Total Ops | -22.97 | -130.69 | -2,678.17 | -54,487.95 | -132,861.50 |
| EPS Basic Continuous Ops | -23.15 | -133.26 | -2,717.14 | -55,572.23 | -132,879.90 |
| EPS Diluted Total Ops | -22.97 | -130.69 | -2,678.17 | -54,487.95 | -132,861.50 |
| EPS Diluted Continuous Ops | -23.15 | -133.26 | -2,717.14 | -55,572.23 | -132,879.90 |
| EPS Diluted Before Non-Recurring Items | -22.97 | -130.69 | -2,695.78 | -54,487.95 | -133,617.20 |
| EBITDA(a) | $-43,553 | $-28,199 | $-18,697 | $-20,365 | $-33,724 |